Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks

Abstract

Aims Blood pressure variability is associated with increased risk of cardiovascular events, particularly in high-risk patients. We assessed if variability was associated with increased risk of cardiovascular events and death in hypertensive patients at different risk levels. Methods and results The Valsartan Antihypertensive Long-term Use Evaluation trial was a randomized controlled trial of valsartan vs. amlodipine in patients with hypertension and different risks of cardiovascular events, followed for a mean of 4.2 years. We calculated standard deviation (SD) of mean systolic blood pressure from visits from 6 months onward in patients with ≥3 visits and no events during the first 6 months. We compared the risk of cardiovascular events in the highest and lowest quintile of visit-to-visit blood pressure variability, using Cox regression. For analysis of death, variability was analysed as a continuous variable. Of 13 803 patients included, 1557 (11.3%) had a cardiovascular event and 1089 (7.9%) died. Patients in the highest quintile of SD had an increased risk of cardiovascular events [hazard ratio (HR) 2.1, 95% confidence interval (95% CI) 1.7-2.4; P Conclusion Higher visit-to-visit systolic blood pressure variability is associated with increased risk of cardiovascular events in patients with hypertension, irrespective of baseline risk of cardiovascular events. Associations were stronger in younger patients and in those with lower mean systolic blood pressure.

Overview

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehx760

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Cited by

See all 227

Metadata

Authors
Mehlum, M. H., Liestøl, K., Kjeldsen, S. E., Julius, S., Hua, T. A., Rothwell, P. M., Mancia, G., Parati, G., Weber, M. A., & Berge, E.
Affiliations
  • Oslo University Hospital (NO)
  • University of Oslo (NO)
  • University of Michigan (US)
  • Novartis (United States) (US)
  • John Radcliffe Hospital (GB)
  • University of Milano-Bicocca (IT)
  • IRCCS Istituto Auxologico Italiano (IT)
  • State University of New York (US)
Corresponding author
Berge, Eivind
Venue
European Heart Journal
Published
2018-01-20
Volume
39
Issue
24
Pages
2243-2251
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2788982091
Cited by
227
References
35
Citations by year
2026: 11 · 2025: 31 · 2024: 24 · 2023: 25 · 2022: 28 · 2021: 43 · 2020: 29 · 2019: 24 · 2018: 11
FWCI
13.53
Type
journal article
Language
en
Open access
closed
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
Funders
  • Norwegian ExtraFoundation
  • Norwegian Health Association
  • Novartis Pharma AG
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Keywords
blood pressure variability, hypertension, cardiovascular events, cardiovascular mortality, baseline cardiovascular risk, valsartan, amlodipine, antihypertensive therapy, established cardiovascular disease, young patients
MeSH terms
Valsartan, Aged, Antihypertensive Agents, Blood Pressure, Female, Heart Failure, Humans, Hypertension, Male, Middle Aged, Mortality, Myocardial Infarction, Prognosis, Proportional Hazards Models, Amlodipine, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. https://app.cochat.ai/papers/10.1093/eurheartj/ehx760
The paper
Mehlum, M. H., Liestøl, K., Kjeldsen, S. E., Julius, S., Hua, T. A., Rothwell, P. M., Mancia, G., Parati, G., Weber, M. A., & Berge, E. (2018). Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. European Heart Journal. https://doi.org/10.1093/eurheartj/ehx760

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.